A recent research report by MarkNtel Advisors has projected that the Global Minimally Invasive Gastrointestinal Surgical Systems Market will grow at around 7% CAGR during 2022-27. The rapidly increasing registration of GI diseases like colorectal cancer, GERD, hernia, & inflammatory bowel syndrome (IBS), i.e., owing to the unhealthy eating habits & changing lifestyles of people is the prime aspect predicted to propel the industry’s expansion in the coming years.
It, in turn, is demonstrating a rise in the demand for Minimally Invasive Gastrointestinal Surgical Systems and making significant contributions to the market. Moreover, the growing elderly population having higher chances of these illnesses are amongst the prominent consumers of these systems, significantly stimulating the market growth.
Furthermore, rising complications in clinical decision-making, the immense burden on radiologists, and massive investments by the governments & private companies in R&D & healthcare infrastructure, alongside possibilities of promising results in minimally invasive surgeries are the other aspects promulgating the market growth.
Surgical Robotic Systems are emerging as a Prominent Growth Opportunity for the Market
Surgical Robotics are set to make substantial contributions to the Global Minimally Invasive Gastrointestinal Surgical Systems Market growth. It owes principally to the concept being a new approach to treating GI diseases & swiftly gaining popularity worldwide. Besides, growing awareness among people about the advantages like enhanced accuracy, stability, superior range of motion, power backup, & excellent safety, among many others is also demonstrating acceptance for these systems and shaping the industry.
Moreover, across diverse regions, robotics has emerged as a gold standard approach for the treatment of GI disorders as patients have fewer infections, hernias, & less scarring. Today, surgical robots have helped overcome challenges with endoscopy systems like the limited line of sight & provide surgeons with exceptionally advanced hand skills & visions. Hence, surgical robotics holds significant potential for the leading players to participate in the market through 2027.
With Massive Investments in Advanced Surgical Systems in the US, North America to Continue Dominating the Market
On the geographical front, North America holds the largest share in the Minimally Invasive Gastrointestinal Surgical Systems Market. This dominance attributes to the increasing number of world-class medical facilities, massive investments in the healthcare sector by the governments of different countries to bring innovations in different therapeutics, and a high prevalence influx of chronic diseases, especially across countries, like the US & Canada, augmenting the demand for these systems.
Besides, other factors like changing lifestyles, improper eating habits, limited physical activity, & easy availability & frequent intake of therapeutic drugs, resulting in the growing patient pool for various GI diseases are also surging the demand for these systems across diverse healthcare facilities. The same aspect is also generating lucrative opportunities for the players to increase their production & distribution capacities to cater to the rising demands and make contributions to the overall market growth through 2027.
The major companies in the Global Minimally Invasive Gastrointestinal Surgical Systems Market include B. Braun Melsungen AG, Conmed Corporation, Karl Storz SE & Co. KG, Medtronic plc, Olympus Corporation, Stryker Corporation, TransEnterix, Inc., Boston Scientific Corporation, Cook Medical, Inc., Richard Wolf GmbH, Intuitive Surgical, Inc., Ambu A/S, Schölly Fiber Optic GmbH, Xenocor, Inc., Fujifilm Holdings Corporation, and Pentax Medical (Hoya Corporation).
Key Questions Answered in the Research Report